Beam Therapeutics Inc. (BEAM) Eyes Major IPO to Advance Precision Genetic Medicine Revolution
Beam Therapeutics Inc. (BEAM) is preparing for a highly anticipated initial public offering (IPO) that could raise up to $300 million, aiming to fund...
Disc Medicine Inc. (IRON) Eyes IPO to Advance Breakthrough Treatments for Blood Disorders
Disc Medicine Inc. (NASDAQ: IRON) is preparing for a highly anticipated initial public offering (IPO) aimed at accelerating the development of its innovative therapies...
Kenvue Inc. (KVUE) Prepares for $3.5 Billion IPO Spin-Off, Marking Johnson & Johnson’s Strategic Consumer Health Breakaway
Kenvue Inc., the newly independent consumer health company spun off from Johnson & Johnson, is gearing up for a $3.5 billion initial public offering...
GRAIL, Inc. (GRAL) Files for Landmark $500 Million IPO to Accelerate Multi-Cancer Early Detection Expansion
GRAIL, Inc., a Menlo Park–based leader in cancer diagnostics, has filed for a $500 million initial public offering (IPO) expected to debut on the...
Praxis Precision Medicines (PRAX) Readies Secondary IPO to Fund Late-Stage Neurology Drug Pipeline
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a Boston-based biotechnology firm focused on treating central nervous system (CNS) disorders, is preparing a secondary public offering...